Bernstein Clinical Research Center Site Number : 8400014

Cincinnati, Ohio 45236

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Spontaneous Urticaria

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed